CLINICAL_TRIALS
trial_result
· 2013-12-12
Clinical Trial Update: Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy [Phase 2]
Summary
This update notes the completion of a Phase 2 efficacy trial evaluating Z160 for lumbosacral radiculopathy conducted by Zalicus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zalicus | Conditions: Lumbosacral Radiculopathy | Phase 2 | Status: COMPLETED